ASSAY and Drug Development Technologies ASSAY and Drug Development Technologies RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

High-Content Assay Multiplexing for Muscle Toxicity Screening in Human-Induced Pluripotent Stem Cell-Derived Skeletal Myoblasts
ASSAY and Drug Development Technologies, Ahead of Print. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - August 2, 2018 Category: Drugs & Pharmacology Authors: William D. Klaren Ivan Rusyn Source Type: research

Society of Biomolecular Imaging and Informatics 5th Annual Meeting Program September 18 –20, 2018
ASSAY and Drug Development Technologies,Volume 16, Issue 6, Page 361-363, August/September 2018. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - August 1, 2018 Category: Drugs & Pharmacology Source Type: research

Know When You Don't Know: A Robust Deep Learning Approach in the Presence of Unknown Phenotypes
ASSAY and Drug Development Technologies,Volume 16, Issue 6, Page 343-349, August/September 2018. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - August 1, 2018 Category: Drugs & Pharmacology Authors: Oliver D ürr Elvis Murina Daniel Siegismund Vasily Tolkachev Stephan Steigele Beate Sick Source Type: research

High-Content Imaging Approaches to Quantitate Stress-Induced Changes in Nucleolar Morphology
ASSAY and Drug Development Technologies,Volume 16, Issue 6, Page 320-332, August/September 2018. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - August 1, 2018 Category: Drugs & Pharmacology Authors: Jin-Shu He Priscilla Soo Maurits Evers Kate M. Parsons Nadine Hein Katherine M. Hannan Ross D. Hannan Amee J. George Source Type: research

High-Content Screening Campaign to Identify Compounds That Inhibit or Disrupt Androgen Receptor-Transcriptional Intermediary Factor 2 Protein-Protein Interactions for the Treatment of Prostate Cancer
ASSAY and Drug Development Technologies,Volume 16, Issue 6, Page 297-319, August/September 2018. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - August 1, 2018 Category: Drugs & Pharmacology Authors: Ashley T. Fancher Yun Hua Daniel P. Camarco David A. Close Christopher J. Strock Paul A. Johnston Source Type: research

Society of Biomolecular Imaging and Informatics Special Issue
ASSAY and Drug Development Technologies,Volume 16, Issue 6, Page 289-290, August/September 2018. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - August 1, 2018 Category: Drugs & Pharmacology Authors: Myles Fennell Kaylene J. Simpson Source Type: research

Interference Potential of Tannins and Chlorophylls in Zebrafish Phenotypic-Based Assays
ASSAY and Drug Development Technologies, Ahead of Print. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - July 9, 2018 Category: Drugs & Pharmacology Authors: Norazwana Samat Mei Fong Ng Nur Faizah Ruslan Kazuhide Shaun Okuda Pei Jean Tan Vyomesh Patel Source Type: research

Identification of Novel, Structurally Diverse, Small Molecule Modulators of GPR119
ASSAY and Drug Development Technologies,Volume 16, Issue 5, Page 278-288, July 2018. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - July 1, 2018 Category: Drugs & Pharmacology Authors: Ainhoa Nieto Virneliz Fern ández-Vega Timothy P. Spicer Emmanuel Sturchler Pramisha Adhikari Nicole Kennedy Sean Mandat Peter Chase Louis Scampavia Thomas Bannister Peter Hodder Patricia H. McDonald Source Type: research

A Computational Study on the Blocking Ability of Selected Commercially Available Anticancer Drugs and Their Hypothetic Derivatives on the CCR5
ASSAY and Drug Development Technologies,Volume 16, Issue 5, Page 266-277, July 2018. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - July 1, 2018 Category: Drugs & Pharmacology Authors: Rahim Ghadari Yousef Mohammadzadeh Source Type: research

Literature Search and Review
ASSAY and Drug Development Technologies,Volume 16, Issue 5, Page 260-265, July 2018. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - July 1, 2018 Category: Drugs & Pharmacology Authors: Aaron Wilson John Concannon Doug Auld Source Type: research

Drug Repurposing Patent Applications January –March 2018
ASSAY and Drug Development Technologies,Volume 16, Issue 5, Page 253-259, July 2018. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - July 1, 2018 Category: Drugs & Pharmacology Authors: Hermann A.M. Mucke Source Type: research

Drug Repurposing Patent Applications October –December 2017
ASSAY and Drug Development Technologies,Volume 16, Issue 5, Page 247-252, July 2018. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - July 1, 2018 Category: Drugs & Pharmacology Authors: Hermann A.M. Mucke Source Type: research

Drug Repurposing and Artificial Intelligence: From Liaison to Marriage
ASSAY and Drug Development Technologies,Volume 16, Issue 5, Page 231-231, July 2018. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - July 1, 2018 Category: Drugs & Pharmacology Authors: Hermann A.M. Mucke Source Type: research

Discovery of a Tin –Piperonal–Entecavir Schiff Base Compound That Overcomes Multidrug Resistance by Inhibiting P-Glycoprotein
ASSAY and Drug Development Technologies, Ahead of Print. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - June 7, 2018 Category: Drugs & Pharmacology Authors: Rehmat Zaman Ghazanfar Ali Zeeshan Anjum Muhammad Sajid Muhammad Mumtaz Khan Aziz Ahmad Syed Rizwan Abbas Wajid Rehman Source Type: research

Cholesterol Unbound ROR γt Protein Enables a Sensitive Inverse Agonist Screening
ASSAY and Drug Development Technologies, Ahead of Print. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - June 6, 2018 Category: Drugs & Pharmacology Authors: Ryokichi Koyama Yasunori Fukuda Yusuke Kamada Hideyuki Nakagawa Darbi Witmer Geza Ambrus-Aikelin Bi-Ching Sang Masaharu Nakayama Hidehisa Iwata Source Type: research